🔓
Sign in as a Member to unlock the full view of BMRN. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$29.99/mo already a Member? Sign in →
BMRN

BioMarin Pharmaceutical Inc.

Sector: healthcareBiotechnologyNASDAQMarket Cap: $12.31B

BioMarin Pharmaceutical Inc. is a biotechnology company focused on rare genetic diseases, with its strongest political signal being a $2.96M annual physician payment program and a disclosed stock holding by a former President.

Next filing → your inbox
Govt Dependence
5/100
Regulatory Density
95/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL

BusinessWhat BMRN does

BioMarin develops and commercializes therapies for rare genetic diseases. Its revenue is derived from the sale of enzyme replacement and other biologic treatments. The company operates in a highly regulated pharmaceutical market.

12 months past · 3 months futureBMRN activity timeline

$72$60$48 DecJan '26FebMarAprMayJunJulAugSepOctNovDecJan '27Feb ↓ PAST — recorded activity ↑ FUTURE — scheduled markups · pending votes TODAY · Nov 17 $70.24 hi $49.67 lo $57.99 CONGRESS 30 INSIDERS 0 13F FUNDS 30 BILLS 30 Viking Global Investors · + $436M · 2026-06-30AQR Capital Management · OPENED $429M · 2026-03-31Viking Global Investors · + $399M · 2026-03-31Viking Global Investors · - $359M · 2025-12-31AQR Capital Management · - $323M · 2026-06-30Citadel Advisors · + $265M · 2026-03-31Citadel Advisors · - $80M · 2026-06-30Renaissance Technologies · - $79M · 2025-12-31Point72 Asset Management · OPENED $73M · 2026-03-31Citadel Advisors · + $70M · 2025-12-31D.E. Shaw & Co. · + $60M · 2025-12-31Renaissance Technologies · - $58M · 2026-03-31 HR.2001 · passed_one · 2026-07-21 MARKUP · Senate Veterans' Affairs · 2026-11-18MARKUP · Senate Finance · 2026-11-18MARKUP · Senate Health, Education, Labor, and Pensions · 2026-11-18MARKUP · Senate Budget · 2026-11-18MARKUP · Senate Veterans' Affairs · 2026-11-18
Congress
buy sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened + added − trimmed closed holds
Bills
past action (this ticker) upcoming markup (sector) ★ carveout (this ticker)
250 trading days · 0 congressional trades shown · 0 insider buys · 12 13F filings · 1 past bill actions · 5 upcoming markups

Executive Branch ConflictsBMRN held by Trump-administration officials

Lifetime Government AwardsBMRN federal contracts by year

$0
total awarded · 2021–2021
2
contracts on file
2021
peak year ($0)
$0K $0K 2021: $0 across 2 contracts (peak year) $0 2021 2 contracts
Top contracts by award amount
$0K Department of Veterans Affairs 2021-07-29 PALYNZIQ
$0K Department of Veterans Affairs 2021-10-13 PHARMACY EMERGENCY FOR PALYNIQ FOR OKC
1 years · 2 contracts

Smart Money · 13F HoldingsHedge funds holding BMRN

$905.0M
Total BMRN held by tracked 13F funds
7
Funds with BMRN positions
Viking Global Investors $436M +8% 2026-06-30
AQR Capital Management $323M -26% 2026-06-30
Citadel Advisors $80M -70% 2026-06-30
Renaissance Technologies $44M +61% 2026-09-30
Bridgewater Associates $16M +33% 2026-06-30
D.E. Shaw & Co. $5M -67% 2026-06-30
Two Sigma Investments $2M -35% 2026-06-30

Congressional TradesWho in Congress is trading BMRN

2023-03-06 Daniel S. Goldman D-New York · house sale $1,001 - $15,000
2023-03-06 Daniel S. Goldman D-New York · house Sale $1,001 - $15,000
2023-03-14 Ro Khanna D-California · house sale $1,001 - $15,000
2023-03-14 Ro Khanna D-California · house Sale $1,001 - $15,000
2022-05-10 Ro Khanna D-California · house sale $1,001 - $15,000
2022-05-10 Ro Khanna D-California · house Sale $1,001 - $15,000
2021-10-18 Josh Gottheimer D-New Jersey · house sale $1,001 - $15,000
2021-10-18 Josh Gottheimer D-New Jersey · house Sale $1,001 - $15,000
2020-12-30 Gilbert Ray Cisneros D-California · house purchase $15,001 - $50,000
2020-12-30 Gilbert Ray Cisneros D-California · house Purchase $15,001 - $50,000
2020-10-16 Josh Gottheimer D-New Jersey · house purchase $1,001 - $15,000
2020-10-16 Josh Gottheimer D-New Jersey · house Purchase $1,001 - $15,000
30+ trades on file · most recent 2023-04-17

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

Stock awards & option exercises

1
stock awards · $402K market value
2026-09-10 Plenge Robert M Director AWARD 6,140 sh $402K
For BMRN, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.

Bills Affecting BMRNLive legislation impacting this stock

Political ProfileWhere BMRN sits in Washington

[object Object]

STRUCTURAL: High regulatory density from healthcare sector and physician payment program ($2.96M in 2024). EVIDENTIARY: Single executive branch holding (Trump, $1K-$15K bucket) and zero federal contract dollars, lobbying spend, or congressional trades. Net: High structural oversight offset by minimal direct political engagement.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • Heightened scrutiny of physician payment programs under transparency laws
    CMS/Open Payments
    "`get_political_influence.doctor_payments` shows $2.96M in payments to physicians in 2024."

Regulatory opportunities

  • Potential for federal procurement of rare disease therapies
    Department of Veterans Affairs
    "`get_government_precedent.federal_contracts_summary` lists the VA as a contracting agency, though obligation is $0."
Member intelligence layer

Live signals + predictions for BMRN — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $29.99/mo Locked rate forever · cancel anytime

Frequently AskedAbout BMRN & political exposure

Does BioMarin Pharmaceutical Inc. (BMRN) hold federal contracts?
Yes. BioMarin Pharmaceutical Inc. has 2 federal contract awards totaling $0, primarily from agencies including Department of Veterans Affairs. See full contract list and amounts on this page.
Which Trump cabinet officials own BMRN stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in BMRN on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
Has Congress traded BMRN stock?
58 congressional trades by 9 unique members of Congress, most recently on 2023-03-14. See the Congressional Trading panel for politician-by-politician breakdown.
What is BMRN political risk profile?
Government dependence: 5/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.
How does GovGreed track BMRN political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. BMRN data is updated daily from these official federal sources.